Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma.

Shelley MD, Kumar S, Wilt T, Staffurth J, Coles B, Mason MD.

Cancer Treat Rev. 2009 Feb;35(1):9-17. doi: 10.1016/j.ctrv.2008.08.002. Epub 2008 Oct 15. Review.

PMID:
18926640
[PubMed - indexed for MEDLINE]
2.

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.

Kumar S, Shelley M, Harrison C, Coles B, Wilt TJ, Mason MD.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006019. Review.

PMID:
17054269
[PubMed - indexed for MEDLINE]
3.

Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trials.

Shelley MD, Kumar S, Coles B, Wilt T, Staffurth J, Mason MD.

Cancer Treat Rev. 2009 Nov;35(7):540-6. doi: 10.1016/j.ctrv.2009.05.001. Epub 2009 Jun 2. Review.

PMID:
19493624
[PubMed - indexed for MEDLINE]
4.

Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials.

Bria E, Cuppone F, Giannarelli D, Milella M, Ruggeri EM, Sperduti I, Pinnarò P, Terzoli E, Cognetti F, Carlini P.

Cancer. 2009 Aug 1;115(15):3446-56. doi: 10.1002/cncr.24392.

PMID:
19484790
[PubMed - indexed for MEDLINE]
Free Article
5.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
[PubMed - indexed for MEDLINE]
6.

The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer.

See WA, Tyrrell CJ; CASODEX Early Prostate Cancer Trialists' Group.

J Cancer Res Clin Oncol. 2006 Aug;132 Suppl 1:S7-16.

PMID:
16896884
[PubMed - indexed for MEDLINE]
7.

Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis.

Morgan SC, Waldron TS, Eapen L, Mayhew LA, Winquist E, Lukka H; Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care.

Radiother Oncol. 2008 Jul;88(1):1-9. doi: 10.1016/j.radonc.2008.04.013. Epub 2008 May 22. Review.

PMID:
18501455
[PubMed - indexed for MEDLINE]
8.

Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens.

Caubet JF, Tosteson TD, Dong EW, Naylon EM, Whiting GW, Ernstoff MS, Ross SD.

Urology. 1997 Jan;49(1):71-8.

PMID:
9000189
[PubMed - indexed for MEDLINE]
9.

Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary.

Abbas F, Scardino PT.

Urol Clin North Am. 1996 Nov;23(4):587-604. Review.

PMID:
8948413
[PubMed - indexed for MEDLINE]
10.

Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme.

Tyrrell CJ, Payne H, See WA, McLeod DG, Wirth MP, Iversen P, Armstrong J, Morris C; 'Casodex' Early Prostate Cancer Trialists Group.

Radiother Oncol. 2005 Jul;76(1):4-10.

PMID:
16145740
[PubMed - indexed for MEDLINE]
11.

Management strategies for locally advanced prostate cancer.

Jani AB.

Drugs Aging. 2006;23(2):119-29. Review.

PMID:
16536635
[PubMed - indexed for MEDLINE]
12.

Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer.

McLeod DG, Iversen P, See WA, Morris T, Armstrong J, Wirth MP; Casodex Early Prostate Cancer Trialists' Group.

BJU Int. 2006 Feb;97(2):247-54.

PMID:
16430622
[PubMed - indexed for MEDLINE]
13.

Comparative study of the impact of 3- versus 8-month neoadjuvant hormonal therapy on outcome of laparoscopic radical prostatectomy.

Pu XY, Wang XH, Wu YL, Wang HP.

J Cancer Res Clin Oncol. 2007 Aug;133(8):555-62. Epub 2007 Apr 25.

PMID:
17457611
[PubMed - indexed for MEDLINE]
14.

Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review.

Schmitt B, Wilt TJ, Schellhammer PF, DeMasi V, Sartor O, Crawford ED, Bennett CL.

Urology. 2001 Apr;57(4):727-32.

PMID:
11306391
[PubMed - indexed for MEDLINE]
15.

[Adjuvant and neoadjuvant drug therapy for prostate cancer].

Miller K, Lein M, Schostak M, Schrader M.

Urologe A. 2008 Nov;47(11):1460-4. doi: 10.1007/s00120-008-1728-z. Review. German.

PMID:
18813902
[PubMed - indexed for MEDLINE]
16.

Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.

Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P.

Eur Urol. 2009 May;55(5):1003-11. doi: 10.1016/j.eururo.2009.01.046. Epub 2009 Feb 4.

PMID:
19211184
[PubMed - indexed for MEDLINE]
17.
18.

A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.

Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, Morris DL.

Ann Surg Oncol. 2007 Oct;14(10):2702-13. Epub 2007 Jul 26. Review.

PMID:
17653801
[PubMed - indexed for MEDLINE]
19.

Systematic review of early vs deferred hormonal treatment of locally advanced prostate cancer: a meta-analysis of randomized controlled trials.

Boustead G, Edwards SJ.

BJU Int. 2007 Jun;99(6):1383-9. Epub 2007 Mar 6. Review. Erratum in: BJU Int. 2007 Jun;99(6):1390.

PMID:
17346269
[PubMed - indexed for MEDLINE]
20.

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD; Scandinavian Prostate Cancer Group Study 7; Swedish Association for Urological Oncology 3.

Lancet. 2009 Jan 24;373(9660):301-8. doi: 10.1016/S0140-6736(08)61815-2. Epub 2008 Dec 16. Erratum in: Lancet. 2009 Apr 4;373(9670):1174.

PMID:
19091394
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk